MedTrace Logo

Screening CEDM in Intermediate and High-Risk Patient Populations

NCT03859492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 461

Last updated 2023-08-24

No results posted yet for this study

Summary

This research study is being done to determine if Contrast Enhanced Digital Mammography (CEDM) can improve breast cancer detection and can be used as an additional screening method to the standard mammographic screening.

Conditions

Interventions

DEVICE

Contrast Enhanced Digital Mammography

High-resolution, low-energy, full-field digital mammography (FFDM) image and contrast-enhanced image

Sponsors & Collaborators

Principal Investigators

  • Bhavika Patel, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-15
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03859492 on ClinicalTrials.gov